Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation

American Journal of Hematology

Volumn 79, Issue 4, 2005, Pages 299-302

  Ritchie, David S ^a   Sainani, A ^b   D'Souza, A ^b   Grigg, A P ^b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Antiphospholipid; Autoantibody; Graft versus host disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTINUCLEAR ANTIBODY; ANTITHROMBOCYTIC AGENT; AUTOANTIBODY; AUTOANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; STEROID; WARFARIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTICONVULSANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DONOR; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEMORY CELL; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE ACTIVATION; MALE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 23244431806     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20350     Document Type: Article

References (22)

1. Storek J, Saxon A. Reconstitution of B-cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9(6):395-408.
2. Haddad E, Le Deist F, Aucouturier P, et al. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: a single-center study of 22 patients. Blood 1999;94(8):2923-2930.
3. Molrine DC, Guinan EC, Antin JH, et al. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Bone Marrow Transplant 1996;17(6):1149-1155.
4. Lausen BF, Hougs L, Schejbel L, Heilmann C, Barington T. Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient. J Immunol 2004:3305-3318.
5. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol 1990;74(1):118-119.
6. Kishimoto Y, Yamamoto Y, Ito T, et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997;19(10):1041-1043.
7. Berisso GA, van Lint MT, Bacigalupo A, Marmont AM. Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease. Bone Marrow Transplant 1999;23(10):1091-1092.
8. Marazuela M, Steegman JL. Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease. Bone Marrow Transplant 2000;26(11): 1217-1220.
9. + selected peripheral blood cells. Bone Marrow Transplant 1997;20(8):697-699.
10. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 1997;137(1): 130-132.
11. Sturfelt G, Lenhoff S, Sallerfors B, et al. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis 1996;55(9):638-641.
12. Lister J, Messner H, Keystone E, Miller R, Fritzler MJ. Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 1987;24:19-23.
13. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. Transplantation 1988;46:238-240.
14. Sohngen D, Heyll A, Meckenstock G. Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation. Am J Hematol 1994;47:143-144.
15. Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion 2002;42(2):198-204.
16. Panaro F, DeChristopher PJ, Rondelli D, et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant 2004;18(3):332-335.
17. Snowden JA, Atkinson K, Kearney P, Brooks P, Biggs JC. Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplant 1997;20(1):71-73.
18. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus crythematosus. N Engl J Med 2003;349(16):1526-1533.
19. Ratanatharathorn V, Carson E, Reynolds C, et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease. Ann Intern Med 2000;133:275-279.
20. Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003;9:505-511.
21. Yamazaki M, Kaneda M, Ito T, et al. Rituximab reduces antiphospholipid antibody (APA) titers and improves hypercoagulability in patients with antiphospholipid syndrome. ASH 2002; Abstract 1027.
22. Kneitz C, Wilhelm, Tony HP. Effective B-cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002;206:519-527.